Globus Medical
(NYSE) GMED
Globus Medical Financials at a Glance
Market Cap
$11.65B
Revenue (TTM)
$2.94B
Net Income (TTM)
$537.90M
EPS (TTM)
$3.93
P/E Ratio
21.92
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$87.25
Volume
22,978
Open
$86.63
Price
$87.25
Volume
22,978
Open
$86.63
Previous Close
$87.25
Daily Range
$85.48 - $87.61
52-Week Range
$51.79 - $101.40
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$87.25
Volume
22,978
Open
$86.63
Previous Close
$87.25
Daily Range
$85.48 - $87.61
52-Week Range
$51.79 - $101.40
GMED News
Investing in Life Sciences Stocks
GMED: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Globus Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
6,000
CEO
Keith W. Pfeil, EMBA
Website
www.globusmedical.comHeadquarters
Audubon, PA 19403, US
GMED Financials
Key Financial Metrics (TTM)
Gross Margin
67%
Operating Margin
16%
Net Income Margin
18%
Return on Equity
12%
Return on Capital
10%
Return on Assets
10%
Earnings Yield
4.56%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$11.65B
Shares Outstanding
135.06M
Volume
22.98K
Short Interest
0.00%
Avg. Volume
1.26M
Financials (TTM)
Gross Profit
$1.98B
Operating Income
$479.80M
EBITDA
$729.90M
Operating Cash Flow
$753.45M
Capital Expenditure
$164.68M
Free Cash Flow
$588.77M
Cash & ST Invst.
$557.24M
Total Debt
$118.66M
Globus Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$826.39M
+25.7%
Gross Profit
$595.13M
+51.1%
Gross Margin
72.02%
N/A
Market Cap
$11.65B
N/A
Market Cap/Employee
$2.20M
N/A
Employees
5,300
N/A
Net Income
$140.63M
+430.6%
EBITDA
$244.39M
+68.2%
Quarterly Fundamentals
Net Cash
$438.59M
+24.3%
Accounts Receivable
$678.94M
+17.4%
Inventory
$759.28M
+15.2%
Long Term Debt
$103.92M
+24.3%
Short Term Debt
$14.74M
-96.8%
Return on Assets
10.14%
N/A
Return on Invested Capital
9.99%
N/A
Free Cash Flow
$192.39M
-0.4%
Operating Cash Flow
$248.59M
+18.2%